A study of the interaction of the alkylating agent, NIH10236, with opioid receptors in vitro and in vivo
- 1 December 1989
- journal article
- research article
- Published by Elsevier in Neuropharmacology
- Vol. 28 (12) , 1349-1356
- https://doi.org/10.1016/0028-3908(89)90009-9
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- An examination of the opiate receptor subtypes labeled by [3H]cyclofoxy: An opiate antagonist suitable for positron emission tomographyBiological Psychiatry, 1988
- [3H]cyclofoxy, a ligand suitable for positron emission tomography, labels mu and kappa opioid receptorsNeuropeptides, 1987
- SITE-DIRECTED ALKYLATION OF MULTIPLE OPIOID RECEPTORS .1. BINDING SELECTIVITY1984
- Specific protection of the binding sites of D-Ala 2 -D-Leu 5 - enkephalin (δ-receptors) and dihydromorphine (μ-receptors)Proceedings of the Royal Society of London. B. Biological Sciences, 1979
- Statistical characterization of the random errors in the radioimmunoassay dose--response variable.Clinical Chemistry, 1976